{"transactions":[{"id":2333353,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-15T21:12:38.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":15272,"price":1.1,"value":16799.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1)."}],"balance_after":236270,"source":{"system":"sec-edgar","filing":"0001209191-22-018883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122018883/doc4.xml","form_type":"4"}},{"id":2333352,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-15T21:12:38.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":15232,"price":1.1,"value":16755.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a correction as to the number of securities previously reported in Column 5 of Table I due to an arithmetical error."}],"balance_after":251542,"source":{"system":"sec-edgar","filing":"0001209191-22-018883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122018883/doc4.xml","form_type":"4"}},{"id":2421135,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-31T22:35:58.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on January 27, 2022 and vest on the same schedule as set forth in footnote (1) above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on January 27, 2022 and vest on the same schedule as set forth in footnote (1) above."}],"balance_after":90000,"derivative":{"underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-005695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122005695/doc4.xml","form_type":"4"}},{"id":2421134,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-31T22:35:58.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 27, 2022 and vests in four equal annual installments on the anniversary of the grant date."}],"balance_after":180000,"derivative":{"exercise_price":1.13,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-22-005695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122005695/doc4.xml","form_type":"4"}},{"id":2789275,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-15T20:05:14.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":11699,"price":8.8428,"value":103451.9172,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1) adopted by the reporting person on May 12, 2020."}],"balance_after":268774,"source":{"system":"sec-edgar","filing":"0001209191-21-020432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121020432/doc4.xml","form_type":"4"}},{"id":2789274,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-15T20:05:14.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":11699,"price":8.8442,"value":103468.2958,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1) adopted by the reporting person on May 12, 2020."}],"balance_after":280473,"source":{"system":"sec-edgar","filing":"0001209191-21-020432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121020432/doc4.xml","form_type":"4"}},{"id":2809019,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-04T22:21:31.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 2, 2021 and vests in four equal annual installments on the anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":10.72,"expiration_date":"2031-03-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-017903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121017903/doc4.xml","form_type":"4"}},{"id":2890448,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2021-01-29T21:00:11.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vested six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vested six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-21-006070","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121006070/doc4.xml","form_type":"4"}},{"id":2890447,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-29T21:00:11.000Z","date":"2021-01-28","kind":"sale","acquired":false,"shares":3443,"price":6.1415,"value":21145.1845,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units."}],"balance_after":292172,"source":{"system":"sec-edgar","filing":"0001209191-21-006070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121006070/doc4.xml","form_type":"4"}},{"id":2890446,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-29T21:00:11.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":11500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock units convert into common stock on a one-for-one basis."}],"balance_after":295615,"source":{"system":"sec-edgar","filing":"0001209191-21-006070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121006070/doc4.xml","form_type":"4"}},{"id":2893550,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-27T21:00:15.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 25, 2021 and vests in four equal annual installments on the anniversary of the grant date."}],"balance_after":175000,"derivative":{"exercise_price":6.8,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-21-005640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121005640/doc4.xml","form_type":"4"}},{"id":3074124,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-29T23:26:24.000Z","date":"2020-07-27","kind":"exercise","acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the\ngrant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the\ngrant date"}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-20-043981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/doc4.xml","form_type":"4"}},{"id":3074123,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-07-29T23:26:24.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":4041,"price":2.4191,"value":9775.5831,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units."}],"balance_after":284115,"source":{"system":"sec-edgar","filing":"0001209191-20-043981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/doc4.xml","form_type":"4"}},{"id":3074122,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-07-29T23:26:24.000Z","date":"2020-07-27","kind":"exercise","acquired":true,"shares":11500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock units convert into common stock on a one-for-one basis."}],"balance_after":288156,"source":{"system":"sec-edgar","filing":"0001209191-20-043981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/doc4.xml","form_type":"4"}},{"id":3105628,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-06-18T22:07:49.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest in two equal installments with the first fifty percent vesting on March 11, 2021 and the second fifty percent on March 11, 2022."}],"balance_after":276656,"source":{"system":"sec-edgar","filing":"0001209191-20-037696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120037696/doc4.xml","form_type":"4"}},{"id":3211280,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-03-13T20:53:03.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock.  This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date."}],"balance_after":201656,"source":{"system":"sec-edgar","filing":"0001209191-20-018918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120018918/doc4.xml","form_type":"4"}},{"id":3298806,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-01-29T22:38:09.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in 2 installments. Fifty percent will vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date and will vest automatically as to 100% of the unvested portion of such restricted stock unit grant upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":23000,"derivative":{"exercise_price":0,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-20-005412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120005412/doc4.xml","form_type":"4"}},{"id":3298805,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-29T22:38:09.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 27, 2020 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":47000,"derivative":{"exercise_price":3.47,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001209191-20-005412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120005412/doc4.xml","form_type":"4"}},{"id":3686830,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock\nOption (Right to Buy)","published_at":"2019-01-25T22:05:16.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 23, 2019 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":60000,"derivative":{"exercise_price":22.93,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-19-001954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319001954/doc4.xml","form_type":"4"}},{"id":3698230,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-01-10T21:45:45.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":8542,"price":31.0963,"value":265624.5946,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Amendment corrects arithmetical error as to number of securities in Column 5 of Table I."}],"balance_after":124656,"source":{"system":"sec-edgar","filing":"0000899243-19-000973","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319000973/doc4a.xml","form_type":"4/A","original_submission_date":"2018-11-19"}},{"id":3698229,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-01-10T21:45:45.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":13448,"price":30.6778,"value":412555.0544,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Amendment corrects arithmetical error as to number of securities in Column 5 of Table I."}],"balance_after":133198,"source":{"system":"sec-edgar","filing":"0000899243-19-000973","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319000973/doc4a.xml","form_type":"4/A","original_submission_date":"2018-11-19"}},{"id":3759260,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-11-19T21:11:47.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":8542,"price":31.0963,"value":265624.5946,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form."}],"balance_after":126656,"source":{"system":"sec-edgar","filing":"0000899243-18-029302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318029302/doc4.xml","form_type":"4"}},{"id":3759259,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-11-19T21:11:47.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":13448,"price":30.6778,"value":412555.0544,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."}],"balance_after":132958,"source":{"system":"sec-edgar","filing":"0000899243-18-029302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318029302/doc4.xml","form_type":"4"}},{"id":4055186,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":129111,"kind":"person","name":"Schneider Joel Solomon Zev","position":1,"cik":"0001727649","reported_name":"Schneider Joel Solomon Zev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T01:22:29.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":105677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in four equal installments beginning on February 14, 2019."}],"balance_after":105677,"derivative":{"exercise_price":26.23,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":105677},"source":{"system":"sec-edgar","filing":"0000899243-18-004335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318004335/doc4.xml","form_type":"4"}}]}